AQST
Aquestive Therapeutics, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$3.83
+1.32%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 8.80x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -8.50x
- Price / sales
- 8.89x
- Price / cash flow
- -10.60x
Enterprise value
- Enterprise value
- $441.2M
- EV / sales
- 8.16x
- EV / EBITDA
- -7.19x
- EV / EBIT
- -8.37x
- Market cap
- $480.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026